Nastech Pharmaceutical
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
420 Lexington Ave Rm 300, New York City,...Phone Number
(919) 578-5901Website
www.nastech.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nastech Pharmaceutical
Nastech.com is a premium digital identity available for acquisition or partnership, embodying cutting-edge technology and innovation. Its memorable and concise structure makes it ideal for startups aiming to establish a strong online presence. The name suggests a fusion of nascent and technology, appealing to a variety of tech startups, including software development and biotech companies. Nastech.com promises trust, growth, and success in the global market.Explore more
Popular SearchesNastech Pharmaceutical Company IncNastech PharmaceuticalNastech Pharmaceutical Co IncSIC Code 28,283NAICS Code 32,325Show moreNastech Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nastech Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nastech Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nastech Pharmaceutical is spiking on competitors!
Earning: See what the market has to say on Nastech Pharmaceutical recently announced quarterly report
Check if Nastech Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nastech Pharmaceutical
Click to see if Nastech Pharmaceutical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nastech Pharmaceutical has new funding data
Product Launch: Get notified when Nastech Pharmaceutical launches new products
Recommended Actions
Reach out to Masked Content who joined Nastech Pharmaceutical as Masked Content
Find more new buyers
Compare Similar Companies to Nastech Pharmaceutical
Compare insights from companies similar to Nastech Pharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nastech Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nastech Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nastech Pharmaceutical.
Nastech Pharmaceutical Tech Stack
A closer look at the technologies used by Nastech Pharmaceutical
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Project
Nastech Pharmaceutical has announced that the company has recently rebranded as Adhera Therapeutics, Inc.
Branding
Project
Nastech Pharmaceutical News & Media
Adhera Therapeutics Announces Termination of Tender Offer for Warrants
RESEARCH TRIANGLE PARK, NC, July 02, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that it has terminated its previously announced offer to exchange all of the warrants to purchase shares of the common stock of the Company that the Company issued in connection with its private placements of Series E Convertible Preferred Stock and Series F CAdhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that its Board of Directors has appointed Nancy R. Phelan to serve as Chief Executive Officer of the Company. Ms. Phelan has served as a member of the Board of Directors since October 2018.Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
RESEARCH TRIANGLE PARK, NC and NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Adhera Therapeutics (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, and Alyvant, a company focused on tech-enabled pharma commercialization, today announced a digital co-promotion agreement for Prestalia®, an approved therapy for the treatment of hypertension. Robert Moscato, Jr., CEO of Adhera Therapeutics, commented, ''We are pleasedAdhera Therapeutics' DyrctAxessTM Platform Helps 78% of Patients Adhere to PRESTALIA(R); Achieves Exceptionally High Level of Drug Adherence to an Antihypertensive Medication
Over 200 prescribers have written at least one prescription for PRESTALIA and over 600 patients are taking the medication PRESTALIA was launched in Q3 2018, powered by the Company's proprietary DyrctAxess platform RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / February 6, 2019 / Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, announced today that its proprietary DyrctAxess Technology Plat
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nastech Pharmaceutical
Sign Up For FreeTo access detailed company insights
Nastech.com is a premium digital identity available for acquisition or partnership, embodying cutting-edge technology and innovation. Its memorable and concise structure makes it ideal for startups aiming to establish a strong online presence. The name suggests a fusion of nascent and technology, appealing to a variety of tech startups, including s... Read More
